发明授权
- 专利标题: Intestinal brake inducing intraluminal therapeutic substance eluting devices and methods
- 专利标题(中): 肠内制动诱导管腔内治疗物质洗脱装置及方法
-
申请号: US13104313申请日: 2011-05-10
-
公开(公告)号: US08876761B2公开(公告)日: 2014-11-04
- 发明人: Thomas E. Albrecht , Jeffrey L. Aldridge , Sean P. Conlon , Michael S. Cropper , Denzel Z. Herrera-Davis , Daniel F. Dlugos, Jr. , Jason L. Harris , Christopher J. Hess , Prasanna Malaviya , Glenda C. Marsh , Mark S. Ortiz , Mark D. Overmyer , Alessandro Pastorelli , Galen C. Robertson , Frederick E. Shelton, IV , Michael J. Stokes , James W. Voegele , Lauren S. Weaner , William B. Weisenburgh, II , Christopher W. Widenhouse , Tamara S. Vetro Widenhouse , James A. Woodard, Jr. , David C. Yates , Mark S. Zeiner , Andrew M. Zwolinski
- 申请人: Thomas E. Albrecht , Jeffrey L. Aldridge , Sean P. Conlon , Michael S. Cropper , Denzel Z. Herrera-Davis , Daniel F. Dlugos, Jr. , Jason L. Harris , Christopher J. Hess , Prasanna Malaviya , Glenda C. Marsh , Mark S. Ortiz , Mark D. Overmyer , Alessandro Pastorelli , Galen C. Robertson , Frederick E. Shelton, IV , Michael J. Stokes , James W. Voegele , Lauren S. Weaner , William B. Weisenburgh, II , Christopher W. Widenhouse , Tamara S. Vetro Widenhouse , James A. Woodard, Jr. , David C. Yates , Mark S. Zeiner , Andrew M. Zwolinski
- 申请人地址: US OH Cincinnati
- 专利权人: Ethicon Endo-Surgery, Inc.
- 当前专利权人: Ethicon Endo-Surgery, Inc.
- 当前专利权人地址: US OH Cincinnati
- 代理机构: Frost Brown Todd LLC
- 主分类号: A61M31/00
- IPC分类号: A61M31/00 ; A61K9/00 ; A61M5/142 ; A61F5/00 ; A61N1/05 ; A61M39/02 ; A61F2/04 ; A61N1/36 ; A61N1/372
摘要:
Methods and devices create an intestinal braking effect, are non-invasive or minimally invasive, and may be reversible. These methods and devices are accomplished via stabilized implantable systems and ingestible pills. In one embodiment, a method of producing satiety comprising the steps of accessing a gastrointestinal tract of a patient and implanting an intraintestinal therapeutic substance eluting implant. The implant is capable of eluting a satiety inducing substance selected from at least one of a nutrient, a specific satiety inducing bio-active substance, pancreatic polypeptides, free fatty acids, cholecystokinin, amino acids, glutamine, lipids, linoleic acid, or a combination thereof, from the implant into the gastrointestinal tract.
公开/授权文献
信息查询